TMC Life Sciences (0101.KU) - Malaysia
(4th) quarter ended Jun 30:
Figures Are In Ringgit (MYR).
2025 2024
Revenue 93,273,000 74,124,000
PreTax Profit 3,054,000 341,000
Net Profit 2,423,000 1,024,000
Earnings Per Share 0.14 Sen 0.06 Sen
Dividend 0.19 Sen 2.22 Sen
12 months ended Jun 30:
Revenue 345,538,000 346,418,000
PreTax Profit 7,072,000 52,621,000
Net Profit 3,606,000 40,648,000
Earnings Per Share 0.21 Sen 2.33 Sen
Dividend 0.19 Sen 2.22 Sen
(END) Dow Jones Newswires
August 26, 2025 06:36 ET (10:36 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.